Vemurafenib - National Cancer Institute

Vemurafenib

(VEH-myoo-RA-feh-nib)
This page contains brief information about vemurafenib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s):		Zelboraf
FDA Approved:		Yes

FDA Approval for Vemurafenib
Use in Cancer
Vemurafenib is approved to treat:

• Melanoma that cannot be removed by surgery or has metastasized (spread to other parts of the body). It is used in patients who have a certain mutation in the BRAF gene.

Vemurafenib is also being studied in the treatment of other types of cancer.
More About Vemurafenib
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results
Clinical Trial Results: New Therapies Offer Valuable Options for Patients with Melanoma - Important clinical trial results for this drug, background information, and how the trial was done.
FDA Approves New Drugs to Treat Skin, Blood, and Lung Cancers - Information about the use of this drug to treat cancer.
Clinical Trials Accepting Patients
Find Clinical Trials for Vemurafenib - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this Web page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.

Vemurafenib - National Cancer Institute